#99: Centaurs & Unicorns 🦄
The one minute healthtech roundup. Now also in podcast form.
Hi friends,
This week: Birdie confirms avian supremacy with $30m series B, interestingly named pod does excellent job, and what are the post COPI copi-ng mechanisms?
PLUS you can listen to us discussing and analysing this week’s news stories on episode 2 of the Healthtech Pigeon podcast 👇🏼 Give it a whirl ahead of Monday and sound well smart at the 9am all-hands 🙌🏾
News Bites 🥪
🐤 Social care SaaS maker Birdie tops up with $30M - U.K.-based caretech software-as-a-service maker closes a $30 million Series B. Rumours that co-founder Rajiv Tanna is on this week’s Healthtech Pigeon podcast are both accurate and true.
🚺 Fertility and Period Apps Can Be Weaponized in a Post-Roe World - Search history and other data has already been used as evidence to criminalise those seeking an abortion in US states with stringent local laws.
💽 What does the end of COPI mean for digital health innovation? - How will the industry copi with the change? Is it a model we could copi for the future? Copi-ous amounts of data will no longer be sharable. Aaaaand I’m spent.
🏋️♀️ Who are the most active PE investors in healthcare? - All the usual suspects, plus 1 or 2 you might not expect.
🏛 As Sajid Javid outlines a digital NHS, tech needs to learn the health service’s values - Is it time to remember why we’re in healthtech? Some of the UK’s best known healthtech firms are going through something of a wobble - profits or patients first?
🏅 Credentialing platform Medallion raises $35M and more digital health fundings - Their Series C takes them to a total raise of $85 million in their quest to license, credential and monitor provider networks
What to Listen to 🔊
🐦 The Healthtech Pigeon Podcast - Ok ok, this week it’s in twice, but James, Jess, & Henry are joined by Birdie Care’s Rajiv Tanna in a podcast described by one listener as “sizzling” & “a feast for the senses. Mainly the ear senses”*
😎 Biotech Bros: How to Navigate Biotech with Maxim Jacobs - Yes that is the podcast’s name. Annoyingly it’s really good. Maxim has years of experience in biotech investing and discusses the recent biotech market fluctuations and sell-off. TLDL - We’ll be fine.
Opportunities 🕵️♀️
🏡 Senior Software Engineer, Kheiron Whenever Pigeon sees Kheiron’s name in the wild, it finds itself hoping they’re named after the wisest of the Centaurs, Chiron, and not an estate agent from Colchester called Keiran. We may never know.
🧠 Senior Director of Product Management, Proximie - Carved out a chunky $80m series C last month. Want to help an excellent UK startup share the best clinical practice?
*Yeah, alright, fine. It was me who said these things. Still a listener though aren’t I? Sue me.